Skip to content

Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility

Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02339272
Enrollment
50
Registered
2015-01-15
Start date
2008-01-31
Completion date
2015-01-31
Last updated
2015-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Spermatogenesis, Azoospermia

Keywords

meiosis, synapsis, recombination, sperm aneuploidy

Brief summary

The aim of this study was to assess meiotic recombination in primary spermatocytes, synaptonemal complex length and the correlation with chromosomal abnormalities in testicular spermatozoa from infertile men with idiopathic non-obstructive azoospermia (NOA).

Detailed description

During the first meiotic division in spermatogenesis there are two critical events. First, synapsis between homologous chromosomes and formation of the synaptonemal complex (SC), which regulates sister chromatid cohesion and provides the template for localization of recombination machinery proteins. Secondly, recombination between homologous chromosomes, which is essential for the correct segregation. Errors during these two processes may induce incorrect segregation of chromosomes and are a major cause of gamete aneuploidy. The aim of this study was to assess meiotic recombination in primary spermatocytes, synaptonemal complex length and the correlation with chromosomal abnormalities in testicular spermatozoa from infertile men with idiopathic non-obstructive azoospermia (NOA). Prospective cohort study to assess meiotic progression, total length of SC, frequency of recombination and sperm aneuploidy in samples obtained from testicular biopsies from NOA patients. The study group was compared with a control group from post-vasectomized (OA) patients. Immunocytogenetics with SCYP3, CREST and MLH1 antibodies for meiotic progression, SC length, and recombination. Fluorescence in situ Hybridization (FISH) for chromosomes 1, 4, 6, 13, 16, 18, 21, 22 in primary spermatocytes and chromosomes 13, 18, 21, X, Y on sperm. MicroMeasure 3.3 program was used for SC length.

Interventions

OTHERnon interventional

Sponsors

Instituto Universitario IVI
CollaboratorOTHER
Igenomix
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* NOA patients undergoing ICSI with testicular sperm * OA post-vasectomized patients undergoing ICSI with testicular sperm

Exclusion criteria

* Abnormal Karyotype

Design outcomes

Primary

MeasureTime frameDescription
Meiotic recombinationonceNumber of MLH1 foci in pachytene cells

Secondary

MeasureTime frameDescription
Sperm aneuploidyoncePercentage of sperm with aneuploidies

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026